Disease: invasive pulmonary aspergillosis (IPA)

Aspergillus fumigatus dsRNA virus promotes fungal fitness and pathogenicity in the mammalian host

mycolabadmin

Researchers discovered that a virus infecting the dangerous fungus Aspergillus fumigatus actually helps the fungus survive and cause worse infections in humans. By removing the virus from fungal strains, scientists found that the fungus became weaker and less able to cause disease in mice. Importantly, treating infected mice with an antiviral drug (ribavirin) reduced the viral load and helped the mice survive, suggesting a new approach to treating serious fungal infections.

Read More »

Occurrence of Pathogenic and Allergenic Molds in the Outdoor and Indoor Environment of a Major Hospital and Molecular Epidemiology of Aspergillus fumigatus in Kuwait

mycolabadmin

Researchers studied molds found in and around a major hospital in Kuwait over 17 months, collecting over 6,000 mold samples. They discovered various mold species, including some that can cause serious infections in hospital patients. Importantly, they found drug-resistant Aspergillus fumigatus strains both outdoors and inside the hospital, suggesting the environment may be a source of infection for vulnerable patients. The findings highlight the need for better monitoring and control of molds in hospital settings.

Read More »

Influenza-related invasive pulmonary aspergillosis in an infectious disease ward at a pulmonary referral center in Iran

mycolabadmin

This study examined patients hospitalized with influenza who developed a serious fungal infection caused by Aspergillus fungus. Among 109 influenza patients, about 9% developed this fungal complication which significantly increased their risk of death and required longer hospital stays. Patients with existing lung diseases were at higher risk, and those with the fungal infection also had more bacterial superinfections. The findings highlight the importance of recognizing and treating this serious fungal complication in hospitalized influenza patients.

Read More »
Scroll to Top